{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T19:10:03Z","timestamp":1758568203672,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.therap.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T01:39:49Z","timestamp":1564191589000},"page":"295-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Medication errors involving opioid maintenance therapy"],"prefix":"10.1016","volume":"75","author":[{"given":"Sophie","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Eiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Rasanjison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Peyri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"\u00c9tude \u00ab\u00a0U. TOPIA\u00a0\u00bb Utilisation des traitements de substitution aux opiac\u00e9s en France\u00a0: analyse des donn\u00e9es de l\u2019assurance maladie de 2009\u00a0\u00e0 2015","author":"Pariente","key":"10.1016\/j.therap.2019.07.007_bib0070"},{"issue":"18","key":"10.1016\/j.therap.2019.07.007_bib0075","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.therap.2019.07.007_bib0080","article-title":"Generalizing the use of a multidimensional approach to move towards an effective Addictovigilance","author":"Jouanjus","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.therap.2019.07.007_bib0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2515\/therapie\/2008062","article-title":"Un exemple de compl\u00e9mentarit\u00e9 entre l\u2019\u00e9valuation des Centres R\u00e9gionaux de Pharmacovigilance (CRPV) et celle des Centres d\u2019\u00c9valuation et d\u2019Information sur la Pharmacod\u00e9pendance (CEIP)","volume":"63","author":"Victorri-Vigneau","year":"2008","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2019.07.007_bib0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont Salam\u00e9","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2019.07.007_bib0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.therap.2017.01.010","article-title":"Surveillance system on drug abuse interest of the French national OPPIDUM program of French addictovigilance network","volume":"72","author":"Frauger","year":"2017","journal-title":"Therapie"},{"year":"2015","series-title":"Medication errors","author":"EMA","key":"10.1016\/j.therap.2019.07.007_bib0100"},{"year":"2008","series-title":"Guichet erreurs m\u00e9dicamenteuses\u00a0: pr\u00e9sentation et bilan depuis la mise en place","author":"ANSM","key":"10.1016\/j.therap.2019.07.007_bib0105"},{"year":"2018","series-title":"Les erreurs m\u00e9dicamenteuses en ville","author":"ANSM","key":"10.1016\/j.therap.2019.07.007_bib0110"},{"key":"10.1016\/j.therap.2019.07.007_bib0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.therap.2018.09.070","article-title":"Improve the benefit\/risk balance of methadone by respecting its pharmacological specificities","volume":"74","author":"Frauger","year":"2019","journal-title":"Therapies"},{"issue":"12","key":"10.1016\/j.therap.2019.07.007_bib0120","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00228-015-1931-y","article-title":"Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction","volume":"71","author":"Diot","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2019.07.007_bib0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.therap.2018.06.004","article-title":"Illogical association nalmefene and opioids: analysis in the French pharmacovigilance database","volume":"74","author":"Favreliere","year":"2019","journal-title":"Therapies"},{"issue":"2","key":"10.1016\/j.therap.2019.07.007_bib0130","first-page":"28","article-title":"Rayon nouveaut\u00e9\u00a0: gare aux \u00ab\u00a0hybrides\u00a0\u00bb\u00a0! Illustration avec l\u2019Orobupr\u00e9\u00ae","volume":"26","author":"De Germay","year":"2019","journal-title":"Bull Info Pharmacol Region Occitanie"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719301246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719301246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:53:32Z","timestamp":1758567212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595719301246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0040595719301246"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2019.07.007","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication errors involving opioid maintenance therapy","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}